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Graphical abstract 
 
We used arrays of subnanoliter wells (nanowells) to monitor the dynamics of individual NK cell-
target cell interactions and quantify the resulting cytolytic and secretory responses.  
 
 
 
 
 
 
Insight statement 
 
The cytolytic and secretory activities of natural killer (NK) cells are important components of the 
innate immune response against potentially harmful target cells. We developed a nanowell-based 
platform to efficiently acquire multiparametric measurements of encounters between individual 
NK cells and tumor target cells. The integrated profiles of contact behavior, motility, lysis, and 
secretion yielded new insights into the heterogeneities and correlations of these parameters at the 
single-cell level. We found that NK cells lyse targets in an autonomous, history-dependent 
manner, and that the target cell-induced secretory activity of individual NK cells associated with 
their migratory characteristics. This technology can be adapted to investigate, with single-cell 
resolution, the dynamic and functional attributes of other cellular systems of interest. 
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Abstract 
Natural killer (NK) cells are a subset of innate immune lymphocytes that interrogate potential 
target cells and rapidly respond by lysing them or secreting inflammatory immunomodulators. 
Productive interactions between NK cells and targets such as tumor cells or virally infected cells 
are critical for immunological control of malignancies and infections. For individual NK cells, 
however, the relationship between the characteristics of these cell-cell interactions, cytolysis, and 
secretory activity is not well understood. Here, we used arrays of subnanoliter wells (nanowells) 
to monitor individual NK cell-target cell interactions and quantify the resulting cytolytic and 
secretory responses. We show that NK cells operate independently when lysing a single target 
cell and that lysis is most probable during an NK cell’s first encounter with a target. 
Furthermore, we demonstrate that the secretion of interferon-γ (IFN-γ) occurs most often among 
NK cells that become the least motile upon contacting a target cell but is largely independent of 
cytolysis. Our findings demonstrate that integrated analysis of the cell-cell interaction 
parameters, cytolytic activity, and secretory activity of single NK cells can reveal new insights 
into how these complex functions are related within individual cells.  
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Introduction 
Natural killer (NK) cells are granular lymphocytes classically defined by their capacity to 
recognize and kill tumor or virally infected cells without the need for antigen sensitization. They 
can also secrete cytokines and chemokines that promote the induction of a robust immune 
response.1,2 NK cells identify target cells using a variety of activating and inhibitory germline-
encoded surface receptors.3,4 The integration of signals from these receptors regulates the cells’ 
cytolytic and secretory responses.5-9 In addition, cytokines such as interleukin-2 (IL-2) from T 
cells,10-13 interferon-α (IFN-α) from plasmacytoid dendritic cells (pDCs),14 and IL-12, IL-15, and 
IL-18 from macrophages and DCs15-19 can significantly enhance cytotoxicity and secretion of 
cytokines from NK cells. 
Recent data have shown that NK cells perform several contact-dependent 
immunomodulatory functions in addition to directly eliminating target cells.2 For example, NK 
cells can tune the development of antiviral adaptive immunity by eliminating virus-infected 
DCs,20 by maturing and ‘editing’ pools of DCs to optimize antigen presentation,21,22 or by lysing 
and suppressing activated T cells.23,24 In these regulatory interactions, as well as in direct 
interactions with target cells, the efficacy of the NK cell-mediated immune response is 
determined by the cytolytic and secretory decisions that each NK cell makes upon encountering 
another cell. The direct relationship between cell-contact parameters, cytolysis, and the secretion 
of cytokines is challenging to study, however, due to the large cell-to-cell variability in both the 
functional capacities of NK cells1,7,15,25-27 and the dynamics of NK cell interactions (e.g., duration 
of conjugation, time to lysis, motility).28-32  
This functional diversity motivates the study of NK cell-mediated cytolysis, secretion, 
and interaction dynamics for individual NK cells. Conventional technologies, however, cannot 
efficiently match observations of these traits with single-cell resolution. Standard microscopy-
based approaches offer sub-cellular imaging resolution of cell-cell interactions but are limited in 
throughput and are not amenable to measuring cytokine production from untransfected human 
cells. Lysispot/ELISpot assays enable the concurrent detection of cytolysis and secretion33 but 
are not conducive to monitoring interactions over time. Finally, flow cytometry, combined with 
intracellular cytokine staining (ICS), provides robust measures of the phenotypic and functional 
attributes of large numbers of single NK cells but de-couples the history of cell-cell interactions 
from the functional readout.  
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Multiple functional properties of NK cells can be measured at the single-cell level by 
isolating and monitoring individual NK cells in submicroliter wells (microwells) or subnanoliter 
wells (nanowells). This approach has been used to demonstrate that the lysis of 293T target cells 
colocalized with IL-2-activated primary human NK cells in nanowells occurs with diverse 
dynamics—some targets display a rapid loss of calcein (a live-cell dye) when they are lysed by 
an NK cell, some display a slow loss of calcein, and others remain unlysed despite being 
contacted by an NK cell.30 Analyses in microwells have also shown that individual primary 
human NK cells undergo dynamic changes in their migratory behavior by transitioning between 
directed migration, random migration, and periods of transient arrests in migration.32 
Microscopy-based assays using micro- and nanowells are well suited for monitoring 
cytolytic activity and motility, but to date there has not been an analytical process that directly 
integrates the measurement of these dynamic behaviors with other functional outcomes, such as 
secretory activity, at the single-cell level. Because one of the primary functions of NK cells is to 
secrete cytokines that orchestrate immune responses to pathogens and malignant cells,1,2 we 
developed a nanowell-based approach to concomitantly relate the secretory activity of individual 
NK cells to the dynamics of their interactions with target cells. Using this integrated process, we 
monitored hundreds of isolated NK cell-target cell interactions in parallel and analyzed the 
relationship between cytolytic activity, secretory activity, and motility. We found that the acute 
secretion of IFN-γ from an NK cell is associated with its motility during contact with the target 
cell but is not associated with the cytolytic outcome of the encounter. 
 
 
 
 
 6 
Methods 
Cells and stimulations 
Human peripheral blood mononuclear cells (PBMCs) were isolated from whole blood by Ficoll-
Hypaque (Sigma-Aldrich) gradient centrifugation. Study subjects were drawn from a healthy 
donor cohort at the Massachusetts General Hospital in Boston. The Partners Healthcare 
Institutional Review Board and the Massachusetts Institute of Technology Committee on the Use 
of Humans as Experimental Subjects approved the study, and each subject gave written informed 
consent. NK cells were isolated from PBMCs by negative selection (EasySep Human NK Cell 
Enrichment Kit; STEMCELL Technologies) and maintained in complete media (RPMI 1640 
(Mediatech) supplemented with 10% heat-inactivated fetal bovine serum (PAA), 2 mM L-
glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin, and 10 mM HEPES buffer (all from 
Mediatech)). Where indicated, NK cells were stimulated with IL-2 (50 U/mL; NIH AIDS 
Research & Reference Reagent Program), IFN-α (10 ng/mL; PBL InterferonSource), IL-12 (10 
ng/mL), IL-15 (100 ng/mL), or IL-18 (100 ng/mL) (all from R&D Systems). The major 
histocompatibility complex (MHC) class I-deficient K562 cell line (ATCC) was maintained in 
complete media and used as a model target cell.  
 
Fabrication of nanowell arrays 
Arrays of poly(dimethylsiloxane) (PDMS; Dow Corning) nanowells containing either 30 µm or 
50 µm cubic wells were prepared by injection molding, as described previously34-36 and in the 
Supplemental Methods.  
 
Single-cell cytolysis assay and video microscopy 
The single-cell cytolysis (SCC) assay was adapted from an assay we recently developed to 
identify antigen-specific cytolytic CD8+ T cells.36 The assay operates by loading small groups 
(~1–5 cells/well) of effector and target cells on an array of nanowells and observing the cytolytic 
encounters that occur in each well (Fig. 1A). Fluorescently labeled NK cells (calcein violet, 1 
µM; Invitrogen, or for video microscopy, eFluor 670, 0.5 µM; eBioscience) and target cells 
(CellTracker Red, 2.5 µM; Invitrogen) were adjusted to a density of 5 × 105 cell/mL and loaded 
onto the arrays. Arrays with 30 µm or 50 µm cubic wells were used to favor the loading of single 
or multiple targets per well, respectively. Media containing SYTOX green (nucleic acid stain to 
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identify dead cells, 0.5 µM; Invitrogen) was applied and the arrays were covered with lifter slips 
(Electron Microscopy Sciences) or glass slides.  
Arrays were imaged using an automated inverted epifluorescence microscope (Axio 
Observer; Carl Zeiss, 10x/0.3 objective) fitted with an EM-CCD camera (ImagEM; Hamamatsu). 
For the SCC assay, images were collected at 0 h to determine the initial occupancy of each well 
and at 4 h to validate the occupancy and determine the acquisition of SYTOX by targets. Arrays 
were incubated at 37°C and 5% CO2 between the initial and final images. Video microscopy was 
performed in a similar manner by imaging a subsection of the array at 8 min intervals over a total 
of 4 h. A custom-written script35 was used to process the images. 
 
Microengraving to detect secreted proteins 
The secretion of cytokines and chemokines from the cells residing in each nanowell was 
measured by microengraving using previously reported protocols.34-39 Microengraving measures 
secretory events from both single- and multi-celled wells, but it does not directly attribute 
secretions from multi-celled wells to specific cells within the well. (The cells’ respective 
contributions may be deconvolved based on independently determined knowledge of cellular 
properties (e.g., certain cells do not secrete specific analytes under certain conditions).) Secreted 
macrophage inflammatory protein-1β (MIP-1β, or CC chemokine ligand 4 (CCL4)) and 
interferon-γ (IFN-γ) from each well were captured for 1 h (30 µm wells) or 2 h (50 µm wells) on 
a glass slide coated with the corresponding capture antibodies (Fig. 4A). The resulting 
microarray of captured proteins was then probed with fluorescent detection antibodies and 
imaged. See Supplemental Methods for additional details. 
 
Functional and phenotypic flow cytometry 
For the functional flow cytometric assays, 106 PBMCs were pre-incubated in the presence or 
absence of stimulatory cytokines (as indicated in the text), and then incubated with K562 target 
cells at an effector:target (PBMC:K562) ratio of 10:1 in the presence of 0.5 µg/mL Brefeldin A 
(Sigma-Aldrich), 0.3 µg/mL Monensin (Golgi-Stop, BD Biosciences), and anti-CD107a-PE-Cy5 
antibody (BD Biosciences). After 4 h of incubation, cells were stained using the LIVE/DEAD 
Fixable Blue Dead Cell Stain (Invitrogen), washed, and then incubated for 15 min with the 
following antibodies: anti-CD3-Pacific Blue (PB), anti-CD14-PB, anti-CD19-PB, anti-CD16-
 8 
allophycocyanin (APC)-Cy7, and anti-CD56-phycoerythrin (PE)-Cy7 (all BD Biosciences). 
Cells were then fixed and permeabilized using the Cytofix/Cytoperm solution kit (BD 
Biosciences) according to the manufacturer’s instructions. Intracellular cytokine staining was 
performed for 30 min with anti-IFN-γ-fluorescein isothiocyanate (FITC) and anti-MIP-1β-PE 
(both BD Biosciences). To assess how the different stimulation conditions might affect the 
phenotypes and activation states of NK cells, PBMCs were separately stained with the 
immunophenotypic markers anti-NKG2D-APC, anti-NKp46-PE (both BD Biosciences), anti-
CD69-FITC, and anti-perforin-peridinin chlorophyll protein (PerCP)-Cy5.5 (both eBioscience). 
In all experiments, NK cells were defined as live CD3-CD14-CD19- lymphocytes expressing 
CD56 and/or CD16 (Fig. S1). In separate experiments, surface expression of NKG2D ligands on 
K562 cells was confirmed using anti-UL16 binding protein (ULBP)-1-PE, anti-ULBP-2-PE, 
anti-ULBP-3 (primary) (all from R&D Systems) with goat anti-mouse-APC (secondary), and 
MHC class I chain-related protein A/B (MICA/B)-PE (both BD Biosciences) (Fig. S2). Data 
were acquired on a BD LSRII (BD Biosciences) flow cytometer and analyzed using FlowJo 
software (V9.3.1; Tree Star).  
 
Data analysis  
Raw data were processed as described above and in the Supplemental Methods. In all 
experiments, the wells that were located on the edge of the array were excluded from analysis to 
minimize any potential edge effects. To analyze the video microscopy data, a custom-written 
MATLAB (R2010b; MathWorks) script was used to calculate parameters describing the 
interactions of single NK cells with up to four target cells. Intervals of NK cell-target cell contact 
were manually verified. Custom-written MATLAB scripts were used to correlate data from the 
SCC assay or video microscopy with data from microengraving on a per-well basis. Statistical 
analyses were performed with Prism 5 (GraphPad Software); specific statistical tests are 
indicated in the text. 
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Results  
Individual NK cells lyse target cells when co-incubated in nanowells 
We developed a single-cell cytolysis (SCC) assay to directly measure the cytolytic behavior of 
thousands of individual NK cells (Fig. 1A). NK cells and K562 target cells were co-deposited 
onto an array of 30 µm cubic nanowells to obtain small, isolated groups of cells.  The stochastic 
loading procedure resulted in the majority of the nanowells being filled with 0–3 cells of each 
type (Fig. S3). For the SCC assay, analysis was restricted to the 1,000–5,000 wells per array that 
contained exactly one NK cell and one target cell. After 4 h of co-incubation in the nanowells, 
productive cytolytic interactions were identified by the appearance of SYTOX+ target cells (Fig. 
1A–B). These initial experiments established that thousands of cytolytic and non-cytolytic 
interactions between individual NK cells and targets could be observed in parallel. 
The cytolytic potential of NK cells is strongly modulated by cytokines that are released 
locally during an immune response.11-14,17-19 We therefore assessed how stimulation with 
exogenous cytokines affected the cytolysis measured in the SCC assay (Fig. 1C). Prior to the 
assay, NK cells were incubated for 20 h with media, IL-2, IFN-α plus IL-2, or a combination of 
IL-12, IL-15, and IL-18. In the absence of cytokine stimulation, 7% ± 6% of NK cells in 
nanowells containing a single NK cell and a single target lysed the target. In each experiment, 
this rate was significantly above the 2% ± 1% background death rate of single target cells on the 
same array (P < .0001, Chi-squared with Yate’s correction). Activation of NK cells with 
exogenous cytokines prior to the assay resulted in a significant increase in the frequency of target 
cell death (23–26%) compared with unstimulated NK cells (P < .05, one-way analysis of 
variance (ANOVA) followed by Tukey’s post-test) (Fig. 1C).  
The cytolytic potential of NK cells40 and T cells41 is associated with target cell-induced 
surface expression of CD107a, a degranulation marker. Assays employing flow cytometry 
commonly use CD107a as a surrogate measurement for the cytolytic activity of single NK 
cells.40 We therefore compared the frequency of single-cell cytolysis (measured by the SCC 
assay) with the frequency of NK cells expressing CD107a after 4 h of co-incubation with targets 
(measured by flow cytometry) (Fig. 1C). For each stimulation condition, the frequency of NK 
cells that upregulated CD107a expression was higher than the frequency of cytolytic NK cells 
observed in the SCC assay, but the two measurements were significantly correlated (R2 = 0.89, P 
< .05, Pearson correlation). The discrepancy in the absolute frequencies may be explained by 
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differences in bulk compared to single-cell stimulation, by the fact that CD107a can be expressed 
on the surface of NK cells that have been activated but have not lysed a target,40 or by the fact 
that the acquisition of SYTOX signal marks the end-stages of target cell death (membrane 
permeabilization). Overall, these results demonstrated that the SCC assay monitors the cytolytic 
outcome of thousands of individual NK cell-target cell pairs, and that the cytolytic frequencies 
measured in this assay reflect the cytolytic activity as measured in bulk cultures.    
 
Small groups of NK cells do not cooperate to kill single target cells 
We next quantified the frequency of cytolysis in nanowells containing different numbers of NK 
cells (zero, one, two, or three NK cells) in the presence of a single target to determine whether 
NK cells kill more efficiently in groups than in isolation (Fig. 2A). As expected, increasing the 
number of NK cells in the well led to increased frequencies of cytolysis. To determine whether 
this increase occurred in a cooperative or independent manner, we tested if the observed 
frequency of lysis in wells containing one NK cell could predict the frequency of lysis in wells 
containing multiple NK cells. If NK cells act independently when killing a single target, then the 
predicted frequency of dead targets in wells with n NK cells is 1 – (1 – Pdeath)n, where Pdeath is the 
frequency (probability) of the target cell being lysed when co-located with a single NK cell. We 
found that the observed frequencies of lysis in wells with multiple NK cells were not 
significantly different from the predicted frequencies (P > .05 for 23 of the 24 cases tested, 
Fisher’s exact test) (Fig. 2B). This result suggested that NK cells residing in small groups in 
nanowells operate independently to mediate the acute lysis of a single target cell; in other words, 
they do not attack more effectively as a group than as individuals (e.g., by enhancing the 
cytolytic behavior of neighboring NK cells or by delivering partial lytic hits that cumulatively, 
but not individually, result in lysis). We note that cooperative effects over larger length scales in 
vivo could occur by the selective recruitment of specific subsets of NK cells to the site of 
infection or tumorigenesis.  
 
IL-2-activated NK cells lyse target cells with heterogeneous dynamics and in an 
order-dependent manner 
The induction of functional responses in NK cells depends heavily on the dynamics of contact 
between NK cells and the target cells that they interrogate.28,29 To characterize the dynamics of 
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contact, we performed time-lapse microscopy on a subsection of the array to collect movies of 
single NK cells interrogating 0–4 target cells in 50 µm cubic wells (Fig. 3A and Supplementary 
Videos 1–4). NK cells were stimulated for 44 h in 50 U/mL IL-2 prior to the assay to ensure a 
robust functional response. This stimulation activated NK cells (47% ± 9% CD69+), but did not 
change the expression of NKp46, NKG2D, or perforin compared with unstimulated NK cells 
(Fig. S4).  
NK cells patrolled the nanowells and formed multiple contacts with targets in the wells 
(Fig. 3B). NK cells that formed contacts with targets mediated the cytolysis of one or more 
targets in 25% of the cases (81 out of 324, compiled from two donors). Among cytolytic NK 
cells, the duration of contact with a target prior to lysis (marked by membrane permeabilization) 
ranged from less than 8 min to over 200 min (Fig. 3C). This wide distribution in times implies 
that the initiation and execution of cytolytic activity following contact with a target occurs with 
heterogeneous dynamics.  
The probability of a target cell being lysed depended upon the order in which it was 
contacted by the NK cell—the first target that an NK cell encountered was more likely to be 
lysed than targets that were encountered subsequently (Fig. 3D). A decrease in cytolytic activity 
over sequential encounters with target cells could occur if the cytolytic potential of an NK cell is 
diminished after the delivery of a lytic hit. To test this hypothesis, we examined whether NK 
cells that lysed the first target they encountered were able to lyse other target cells upon 
subsequent contact. Among the NK cells that contacted 2–4 target cells, 27% (37 out of 135) 
lysed the first target that they encountered. Within the group of cells that exhibited cytolytic 
activity upon the first encounter, 19% (7 out of 37) also lysed additional targets that they 
encountered later (e.g., Supplementary Video 4). This result suggested that NK cells retain their 
cytolytic potential after delivering a lytic hit (consistent with previous reports of serial killing31 
and bulk studies demonstrating that NK cells retain perforin and granzyme loading after target 
cell-induced degranulation42), but that only a subset of the initially cytolytic NK cells proceed to 
serially lyse multiple targets. In addition, among the group of NK cells that did not lyse the first 
target, 93% (92 out of 98) also did not lyse any of the other targets that they subsequently 
encountered. This result demonstrated that NK cells that do not lyse the first target they 
encounter are unlikely to exhibit cytolytic activity upon subsequent encounters with similar 
target cells within short periods (4 h). Together, these results suggest that the decrease in 
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cytolytic activity over sequential encounters with target cells occurs because (1) only a fraction 
of NK cells that lyse the first target they encounter continue on to lyse additional targets, and (2) 
NK cells that do not lyse the first target they encounter are unlikely to lyse targets that they 
encounter later.  
 
Microengraving measures the short-term secretory activity of individual NK cells 
In addition to their cytolytic activity, NK cells also contribute to immune control by secreting 
cytokines and chemokines. We used microengraving, a technique to detect the proteins that are 
secreted by the cells residing within each nanowell on the array (Fig. 4A),34-39 to measure the 
short-term secretory profiles of individual NK cells and match them to the corresponding 
observations of the NK cell-target cell interactions (Fig. 4B). We focused our analysis on the 
secretion of MIP-1β and IFN-γ. These proteins are secreted by NK cells and play important roles 
in coordinating the immune response. MIP-1β is a chemokine that can attract NK cells43 and 
other immune cells; it also suppresses human immunodeficiency virus (HIV) infection by 
inhibiting the binding of HIV to CC chemokine receptor type 5 (CCR5).44,45 IFN-γ is a cytokine 
that inhibits viral replication, increases the presentation of antigen, and polarizes the 
differentiation of T helper cells to the Th1 lineage.46  
We first validated that microengraving could detect characteristic patterns of secretory 
activity from NK cells that interacted with target cells. Prior to microengraving, NK cells were 
incubated for 20 h in either media alone or a combination of IL-12, IL-15, and IL-18. NK cells 
were then loaded with target cells into 30 µm cubic nanowells and incubated for 4 h to allow 
interactions with targets to take place. Following incubation, microengraving was performed for 
1 h to capture secreted MIP-1β and IFN-γ, and wells that contained a single NK cell and multiple 
target cells were analyzed for secretion (Fig. 4C). Previous reports have shown that, in the 
absence of activation with exogenous cytokines, MIP-1β is the dominant secretory product from 
NK cells that interact with K562 target cells.7 Similarly, we found that MIP-1β was secreted by a 
small but consistently detectable fraction of NK cells that were cultured in media alone prior to 
being introduced to the target cells in the nanowells (Fig. 4C). NK cells that were activated with 
IL-12, IL-15, and IL-18 prior to the assay exhibited increased secretion of MIP-1β and strong 
secretion of IFN-γ. This finding was consistent with previous reports showing that IL-12, IL-15, 
and IL-18 activate NK cells and induce the secretion of cytokines, especially IFN-γ.7,15,16 
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Analogous assays performed using ICS in combination with flow cytometry produced similar 
trends in relative secretory activity (Fig. 4C). Together, these experiments confirmed that 
microengraving can be used to profile the secretion of MIP-1β and IFN-γ from NK cells 
interacting with target cells in the array of nanowells. 
 
Secretion of IFN-γ from IL-2-activated NK cells is associated with reduced motility 
during contact with target cells 
As a population, NK cells patrol their local microenvironment (e.g., lymph node or tissue), 
interrogate target cells, lyse target cells, and secrete cytokines. How these diverse functional 
parameters are related in each individual NK cell, however, has not been well characterized. To 
address this question, we matched observations of interactions (determined by time-lapse 
microscopy) between single IL-2-activated (50 U/mL, 44 h) NK cells and target cells in 50 µm 
cubic wells to measurements of secreted MIP-1β and IFN-γ collected via microengraving from 
the same nanowells (Fig. 5A). The resulting collection of functional profiles allowed us to 
quantitatively analyze cytolysis, secretion, and the dynamics of interaction in individual NK 
cells.  
We first examined whether target cell-induced secretory activity and cytolytic activity 
were associated for individual NK cells. NK cells that contacted at least one target cell displayed 
robust secretion of MIP-1β and IFN-γ (Fig. 5B). Secretion was not observed in the absence of 
contact with a target, even if a target cell was present in the well. Among NK cells that contacted 
at least one target, however, there was no significant difference in the secretion of MIP-1β or 
IFN-γ between the cytolytic and non-cytolytic groups of NK cells (Fig. 5B). These results 
suggest that acute, target cell-induced secretory activity is not closely correlated to cytolytic 
activity in individual IL-2-activated NK cells.  
To investigate how the dynamics of contact with target cells may regulate cytolysis and 
secretion in single NK cells, we next examined whether the motility of NK cells during contact 
with targets was associated with the subsequent cytolytic or secretory outcome of the encounter. 
The velocities of NK cells during periods of contact with target cells were reduced compared 
with the velocities in the absence of targets or after disengagement from a target (Fig. 5C; P < 
.001, Kruskal-Wallis test followed by Dunn’s post-test). When the velocities of NK cells during 
contact with targets were further segregated based on the functional response (MIP-1β-/+, IFN-γ-
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/+, lysis-/+), we found that cells that secreted IFN-γ had a significantly reduced velocity during 
contact with targets compared with cells that did not secrete IFN-γ (Fig. 5D; P < .05, Mann-
Whitney test), and that these cells remained more arrested at the initial point of contact with the 
target (Fig. 5E). There was no significant difference between the during-contact velocities of NK 
cells that were segregated by the secretion of MIP-1β or cytolytic outcome (Fig. 5D). Together, 
these results suggest that NK cells receive stop signals of varying strengths after contacting a 
target, and that the degree of arrest in motility is related to the subsequent secretion of IFN-γ.  
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Discussion 
NK cells induce cytolysis and secrete chemokines and cytokines in response to malignant or 
infected cells, and thus play a critical role in the immune control of cancer and infectious 
diseases.2,47 Characterizing how individual NK cells interact with, and subsequently respond to, 
potential target cells is important for understanding the mechanisms by which they eliminate 
targets but leave healthy cells unharmed. Our group has recently described the use of arrays of 
nanowells to screen for HIV-specific CD8+ T cells.36 Here, we extended this approach to monitor 
interactions between individual NK cells and K562 target cells and then correlated these 
interactions to linked measurements of the cytolytic and secretory outcomes from the individual 
NK cells. The results of these dynamic, single-cell measurements begin to define the rules of 
engagement that modulate the functionality of NK cells during their response to target cells.  
The unique ability of the SCC assay to precisely count the number of NK cells and 
targets in each nanowell allowed us to quantitatively investigate whether small groups of NK 
cells act cooperatively when killing an isolated target cell. Our results were consistent with a 
model in which each NK cell operates as a cytolytic agent that is independent of other NK cells 
present in the well. The lack of cooperative cytolytic behavior suggests that local paracrine 
signaling (over the sub-nanoliter volume of the well) between NK cells does not induce them to 
work synergistically to kill single target cells within a 4 h interval. This finding, however, does 
not eliminate the possibility for cooperative killing behavior among NK cells when killing 
multiple targets, killing resistant targets, or operating over larger length scales or longer intervals 
of time. Indeed, the bulk self-recruitment of NK cells into regions containing a high density of 
target cells is commonly observed.48,49 In contrast, the self-recruitment of individual NK cells to 
aid in the acute elimination of a single target cell has been observed only on occasion,50 thus 
supporting our finding that local cooperative behavior among NK cells is not a major mechanism 
by which the lysis of single, susceptible targets is achieved. 
The variability in time to lysis that we observed may involve mechanisms by which NK 
cells progress through cytoskeletal polarization checkpoints before delivering a successful lytic 
hit29 or cell-to-cell differences in the kinetics of apoptosis in targets.51 NK cells lyse K562 target 
cells primarily by delivering perforin/granzyme-loaded cytolytic granules into the lytic 
synapse52,53 rather than by triggering death receptor-mediated pathways of apoptosis induced by 
Fas ligand54-56 (FasL) or tumor necrosis factor (TNF)-related apoptosis-inducing ligand57 
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(TRAIL). Some of the heterogeneity in lysis times and behaviors, however, could result from 
NK cells inducing the death of target cells by other mechanisms—for example, by using 
membrane nanotubes to facilitate cytolytic interactions with target cells.58 
Our finding that cytolytic NK cells are most likely to lyse the first target cell they 
encounter suggests that they do not need to integrate activating signals collected during prior 
encounters with targets before overcoming the signaling threshold required for the delivery of a 
lytic hit; instead, they exert their cytolytic activity at the first opportunity. This pattern of 
activation is different from the pattern followed by T cells during priming in the lymph node 
under certain conditions, where it has been shown that the signals received through the T cell 
receptor are integrated over serial encounters with antigen-presenting cells until a threshold of 
activation is reached.59 Because both the density and the type of ligands displayed by target cells 
have a large effect on the functional response of NK cells5-7 it will be interesting to test whether 
different target cells produce different patterns of order-dependent cytolytic activity.  
Cytolysis and secretion are the primary functions of NK cells during an immune 
response. By collecting linked measurements of the cytolytic and secretory activities of 
individual IL-2-activated NK cells upon exposure to target cells, we demonstrated that the acute 
secretion of IFN-γ and MIP-1β is not associated with the cytolytic status of NK cells. Studies 
using bulk mixtures of NK cells and target cells have also suggested that cytolysis and secretion 
may be differentially regulated or temporally distinct.7,60-63 Furthermore, cytokines (e.g., IFN-γ, 
TNF) and perforin-loaded cytolytic granules are sorted into separate endosomes and released in 
distinct fashions from NK cells,60 providing mechanistic support to the idea that cytolysis and 
secretion can be controlled independently within individual cells.   
The relationship between the motility of NK cells and their secretory responses to target 
cells has not previously been analyzed at the single-cell level. Using integrated measurements of 
single, IL-2-activated NK cells, we found that target cell-induced secretion of IFN-γ was 
associated with the motility of the NK cells during contact with targets. The during-contact 
velocity of NK cells that secreted IFN-γ was significantly lower than that of NK cells that did not 
secrete IFN-γ. Previous reports have demonstrated that NK cells display a dose-dependent 
reduction in velocity when exposed to increasing concentrations of surface-bound MICA, an 
NKG2D ligand expressed on K562 target cells, and that these activating signals induce NK cells 
to arrest and form stable synapses with target cells.28 It has also been shown that the level of 
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activation that is necessary to induce the secretion of IFN-γ is higher than that necessary to 
induce degranulation or the secretion of MIP-1β.7 Our findings, therefore, are consistent with a 
model in which NK cells that receive the strongest activating signals upon encounter with a 
target have the lowest during-contact velocity (due to receiving a strong stop signal) and are also 
the most likely to surpass the signaling threshold required to induce the secretion of IFN-γ. A 
similar association between antigen-induced arrest and the secretion of IFN-γ has also been 
observed at the population level in mouse CD4+ T cells.64 Interestingly, we did not detect a 
significant difference in the during-contact motility of cells that did or did not secrete MIP-1β (a 
chemokine), although in other systems of interacting lymphocytes the secretion of chemokines 
has been shown to affect the characteristics of the immune synapse.65 In general, the association 
between the during-contact velocity and the secretion of IFN-γ suggests that, for NK cells, there 
is overlap in the target cell-triggered signaling pathways that control motility and those that 
control the secretion of cytokines. 
 In summary, we have developed and validated a nanowell-based platform to 
quantitatively monitor and correlate the contact dynamics and functional outcomes (cytolysis, 
secretion) of interactions between individual NK cells and target cells.  Integrated measurements 
such as these have not previously been possible to perform at the single-cell level due to the 
constraints of conventional assays. In the present study, we analyzed interactions between NK 
cells and tumor target cells, but the nanowell-based platform presented here could also be used to 
examine cross-regulation between NK cells and virally infected cells, DCs, or T cells with 
single-cell resolution. Moreover, the platform is suitable for use with samples containing a 
limited number of cells (104–105), and thus will enable unprecedented functional analysis of 
clinical biopsy specimens. Such applications could include the analysis of mucosal NK cells in 
HIV infection66 or of intrahepatic NK cells in viral hepatitis.67 In the current study, which 
focused on interactions between peripheral blood NK cells and K562 tumor target cells, we 
demonstrated that local cooperativity among NK cells does not contribute significantly to the 
lysis of single target cells, and that short-term secretory responses arising from individual NK 
cells are correlated with the dynamics of NK cell-target cell interactions but not cytolysis. 
Together, these results illustrate new properties by which NK cells perform immune surveillance 
and mediate the elimination of target cells.  
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Figure legends 
 
Fig. 1 NK cells interrogate and lyse K562 target cells when co-incubated in nanowells. (A) 
Schematic of the single-cell cytolysis (SCC) assay. NK cells and K562 target cells are loaded 
onto an array of nanowells. An initial set of images is acquired to determine the number of cells 
per well; after 4 h of incubation, a second set of images is acquired to identify wells in which a 
killing event occurred (SYTOX+ target cell). (B) Representative images of NK cells (blue) co-
incubated with target cells (red) in the nanowells. Lysed target cells become positive for SYTOX 
(green). (C) Frequencies of cytolytic events measured by the SCC assay and of degranulated NK 
cells measured by flow cytometry after 4 h of NK cell-target cell interactions. NK cells were 
incubated for 20 h with the indicated stimulation conditions prior to either assay. Data from the 
SCC assay were gated to include wells containing a single NK cell and a single target. Target 
cell-induced degranulation is expressed as ΔCD107a, which indicates the difference in 
expression of CD107a on the surface of NK cells that were or were not exposed to target cells in 
bulk. Mean and standard deviation (SD) for at least three donors per condition are shown. ###P 
< .0001, Chi-squared with Yate’s correction comparison of lysis rates of target cells in wells on 
the same array containing zero NK cells (background death) or one NK cell. *P < .05, **P < .01, 
***P < .001, one-way ANOVA followed by Tukey’s post-test.  
 
Fig. 2 NK cells act independently when lysing a single target cell in a nanowell. (A) 
Representative distribution of SYTOX intensity in target cells after being co-incubated for 4 h in 
nanowells with one, two, or three NK cells. Data were gated to include wells containing a single 
target cell. Example images show the initial occupancy of the nanowells for each combination. 
The percentage of lysed target cells (double-positive for SYTOX and CellTracker Red) is 
indicated. In this example, the NK cells were obtained from the donor depicted in gold in the 
plots in Panel B and were activated with IFN-α plus IL-2. MFI, median fluorescence intensity. 
(B) Observed frequencies of cytolysis (filled circles; colors indicate unique donors) in nanowells 
containing 0–3 NK cells. For each donor, the frequencies of cytolysis predicted from the 
frequency observed in wells containing a single NK cell are shown as dotted lines. Prior to the 
assay, NK cells were stimulated with the indicated conditions for 20 h.  
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Fig. 3 Dynamic cytolytic interactions between NK cells and target cells. (A) Representative 
composite micrographs of a single IL-2-activated (50 U/mL, 44 h) NK cell (blue) interacting 
with a target cell (red) and inducing cytolysis (green; SYTOX). Images were acquired every 8 
min for 4 h. For each target cell, the SYTOX intensity and the distance to the NK cell were 
calculated using automated tracking scripts. (B) Distribution of the number of contacts formed 
by single NK cells with distinct target cells over 4 h as a function of the total number of target 
cells residing in each nanowell. (C) Histogram of the total NK cell-target cell contact time 
required for cytolytic NK cells to induce the permeabilization of the membrane of the target cell. 
Data are segregated into pairs of NK cells and target cells that were not yet in contact in the first 
image (dark grey bars) or were already in contact in the first image (light grey bars). (D) Relative 
probability of an NK cell lysing the first, second, third, or fourth target cell that it encountered. 
Groups are segregated based on the total number of distinct target cells that were encountered, 
and relative probabilities were calculated as the fraction of lysed target cells in each group that 
were the nth target cell to be contacted by the NK cell. Panels A–C are representative of two 
independent donors; Panel D shows combined data from both donors.   
 
Fig. 4 Microengraving measures the short-term secretory activity of individual NK cells. (A) 
Schematic of microengraving to detect secreted cytokines and chemokines. A capture antibody-
coated glass slide is placed in contact and incubated with the array of nanowells; this process 
creates a matched microarray of secreted proteins that is subsequently detected with 
fluorescently labeled antibodies, imaged, and analyzed to correlate secretion events to the 
nanowell of origin. (B) Representative matched images measuring cytolytic activity and the 
secretion of proteins from the same NK cell. Labeling is as described in Fig. 1B. (C) Production 
of cytokines and chemokines measured by microengraving or intracellular cytokine staining 
(ICS). NK cells were incubated for 20 h with the indicated stimulation conditions prior to either 
assay and then incubated with target cells in the nanowells (microengraving assay) or in bulk 
(ICS assay) for 4 h. The microengraving data were gated to include wells containing a single NK 
cell and multiple target cells. Mean and SD for at least three donors per condition are shown. 
Note difference in scale between the two graphs. 
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Fig. 5 Secretion of IFN-γ is associated with the velocity of NK cells during contact with target 
cells. (A) Representative composite micrographs of IL-2-activated (50 U/ml, 44 h) NK cell-
target cell interactions and corresponding measurements of secreted chemokines and cytokines. 
Interactions were tracked for 4 h at 8 min intervals using time-lapse microscopy (labeling as 
described in Fig. 3A); microengraving was performed immediately afterward for 2 h to capture 
chemokines and cytokines secreted by each NK cell. Micrographs in rows 1–3 correspond to 
Supplementary Videos 1–3. (B) Secretion of MIP-1β and IFN-γ from single NK cells. NK cells 
are segregated based on whether they contacted a target cell, and, if they did contact at least one 
target cell, whether they exhibited cytolytic activity. Dashed lines indicate the threshold for 
positive secretion events (background + 2 SD). **P < .01, ***P < .001, n.s., not significant, 
Mann-Whitney test. (C) Mean velocities of NK cells in nanowells in the absence of target cells 
(0 K562), during contact with target cells, and after contact with target cells. ***P < .001, 
Kruskal-Wallis test followed by Dunn’s post-test. (D) Mean velocities of NK cells in nanowells 
during contact with target cells. Data are segregated by functional outcome. *P < .05, n.s., not 
significant, Mann-Whitney test. In Panels B–D the mean and standard error of the mean (SEM) 
are indicated in red. (E) Tracks of NK cells in the absence of target cells (left) or during contact 
with a target cell (right). The tracks during contact are segregated by secretory outcome. Each 
plot displays n = 15 tracks that were randomly selected from the pool of all eligible cell tracks. 
All results are representative of two independent donors. 
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Supplemental methods 
 
Fabrication of arrays of nanowells 
Arrays of nanowells containing either 30 µm (248,832 wells/array) or 50 µm (84,672 
wells/array) cubic wells were prepared on 75 × 25 mm2 glass slides (Corning) by injecting a 
silicone elastomer (poly(dimethylsiloxane) (PDMS; Dow Corning), 10:1 ratio of base:catalyst) 
into a mold containing a microfabricated silicon master. PDMS was cured at 80°C for 4 h and 
then released from the mold. Shortly before depositing cells into the array, the arrays were 
treated with an oxygen plasma (Harrick PDC-32G) for 30 s to sterilize the array and render the 
PDMS hydrophilic. Arrays were stored in phosphate-buffered saline (PBS) until use, and were 
washed with complete media prior to cell loading.  
 
Microengraving to detect secreted proteins 
Capture antibodies against MIP-1β (R&D Systems), IFN-γ (Mabtech), and human 
immunoglobulin G (hIgG) (ZyMax; Invitrogen) (10 µg/mL each in borate buffer; pH 9) were 
coated onto poly(L-lysine)-coated glass microscope slides for 1 h at room temperature. Slides 
were then blocked in 1.5% bovine serum albumin (BSA; EMD Chemicals) / PBS-TWEEN20 
(0.05%; Sigma-Aldrich) (PBST) for 30 min, washed once in PBS, dipped in water, and spun dry. 
Prior to microengraving, the cell-loaded arrays of nanowells were rinsed with serum-free media 
containing hIgG (34.5 ng/mL; Athens Research & Technology) to provide a positive background 
signal in every well and facilitate the registration of the features during image analysis of the 
captured protein microarrays. Excess media was aspirated and the capture antibody-coated glass 
slides were placed face down on top of the cell-loaded arrays (Fig. 4A). Compression was 
applied using a microarray hybridization chamber (Agilent). The clamped arrays were incubated 
for 1 h (30 µm wells) or 2 h (50 µm wells) to allow the capture of secreted proteins onto the 
antibody-coated glass slide. The resulting microarrays of secreted proteins were then separated 
from the PDMS array, washed in PBS, blocked with 1.5% BSA-PBST, and hybridized (45 min, 
room temperature) with the following detection antibodies: biotinylated anti-MIP-1β, anti-IFN-γ-
AlexaFluor555, and anti-hIgG-AlexaFluor700 (1 µg/mL each in 0.1% BSA-PBST, all from same 
manufacturers as corresponding capture antibodies). Arrays were washed in PBS and PBST and 
then hybridized an additional 30 min at room temperature with streptavidin-AlexaFluor647 (1 
 S-3 
µg/mL; Invitrogen). After a final series of washes in PBS, PBST, and water, the protein 
microarrays were dried and imaged with 5-µm resolution using a commercial microarray scanner 
(GenePix 4200AL, Molecular Devices).   
The microarray of secreted proteins was analyzed using commercial image processing 
software (GenePix Pro 6, Molecular Devices). The median fluorescence intensity (MFI) in each 
channel was calculated for each spot in the array to determine the relative intensity of secretion 
of the cells in the corresponding nanowell. Data were filtered to exclude spots with saturated 
pixels or high coefficients of variation (>70–90). Spots with a high signal-to-noise ratio (>3–5), 
low relative local background, and MFI > [global background + 2 standard deviations] were 
marked as positive spots. 
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Fig. S1 Flow cytometry gating scheme for NK cells. Numbers indicate percentages within 
each gate. NK cells were defined as live CD3-CD14-CD19- lymphocytes expressing CD56 and/or 
CD16 (i.e., CD56+CD16- (CD56bright NK cells), CD56+CD16+ (CD56dim NK cells) or CD56-
CD16+ (CD56neg NK cells)). 
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Fig. S2  Surface expression of NKG2D ligands on K562 target cells. Black lines represent 
the K562 cells stained with the indicated antibody; grey shaded areas show the respective isotype 
controls.  
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Fig. S3 Distribution of NK cells and K562 target cells in arrayed nanowells. Bar graph of 
the mean and standard deviation (SD) of the numbers of nanowells on each array that contained 
the indicated combinations of NK cells and target cells. Results were compiled from eight arrays 
containing 30 µm cubic nanowells. Each 75 × 25 mm2 array contained 248,832 wells. In all 
experiments, to minimize any potential edge effects, only wells located in the center of the array 
were considered (147,456 wells). Further filtering was performed to exclude wells with dead 
cells at the t = 0 h time-point and wells in which the cell occupancy changed between the images 
acquired at t = 0 h and t = 4 h.  
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Fig. S4 Phenotypes of NK cells after 44 h stimulation with IL-2. NKp46, NKG2D, CD69, 
and intracellular perforin were measured by flow cytometry for freshly isolated NK cells 
(Baseline) or for NK cells stimulated for 44 h in media or in 50 U/ml IL-2. Bar graphs show 
mean and SD for three donors per condition. 
  
 
